RIG
ELV icon

RiverFront Investment Group’s Elevance Health ELV Stock Holding History

RiverFront Investment Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
3,437
+2,536
+281% +$940K 0.02% 210
2026
Q1 		$264K Buy
901
+63
+8% +$20.7K ﹤0.01% 347
2025
Q4 		$294K Buy
+838
New +$283K ﹤0.01% 300

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

RiverFront Investment Group's ELV Position: Q2 2026 in Review

RiverFront Investment Group increased its Elevance Health (ELV) stake by 281% in Q2 2026, buying an estimated $940K and bringing the position to 3,437 shares worth $1.33M. The position accounts for 0.02% of the portfolio, ranked #210.

RiverFront Investment Group first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • RiverFront Investment Group held 3,437 shares of Elevance Health worth $1.33M as of Q2 2026.
  • RiverFront Investment Group bought 2,536 Elevance Health shares in Q2 2026, an estimated $940K.
  • Elevance Health made up 0.02% of RiverFront Investment Group's portfolio in Q2 2026, its #210 holding.
  • RiverFront Investment Group first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on RiverFront Investment Group's 13F filing for Q2 2026, filed 29 Jul 2026.